Relative Strength Chart Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 240.43 USD | +7.19% |
|
+9.59% | +20.53% |
| Jul. 20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| Jul. 13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Other Biotechnology & Medical Research | +7.19% | +9.59% | +20.53% | +34.33% | -39.84% | 10.8B |  | | |
- Stock Market
- Stocks
- CRL Stock
- Charts Charles River Laboratories International, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
